Molecular properties of lysozyme-microbubbles: Towards the protein and nucleic acid delivery

Amino Acids

Volumn 43, Issue 2, 2012, Pages 885-896

  Melino, Sonia ^a   Zhou, Meifang ^b   Tortora, Mariarosaria ^a   Paci, Maurizio ^a   Cavalieri, Francesca ^a   Ashokkumar, Muthupandian ^b  

^a UNIVERSITY OF ROME TOR VERGATA   (Italy)

^b UNIVERSITY OF MELBOURNE   (Australia)

Author keywords

Lactoferrin; Lysozyme; Microbubbles; Nucleic acid delivery; Proteolysis; Ultrasounds

Indexed keywords

DRUG CARRIER; LYSOZYME; NUCLEASE; NUCLEIC ACID; POLYSACCHARIDE; PROTEIN DERIVATIVE;

ARTICLE; BACTERIUM TRANSFORMATION; BIODEGRADABILITY; CONTROLLED STUDY; DNA BINDING; DRUG DELIVERY SYSTEM; MICROBUBBLE; NONHUMAN; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN FOLDING;

ADSORPTION; COLLOIDS; DEOXYRIBONUCLEASE I; DEXTRANS; DNA; DNA CLEAVAGE; DRUG CARRIERS; ENZYME STABILITY; LACTOFERRIN; MICROBUBBLES; MURAMIDASE; PROTEIN BINDING; PROTEOLYSIS; SERUM ALBUMIN, BOVINE; SURFACE PROPERTIES; TRYPSIN;

EID: 84864779356     PISSN: 09394451     EISSN: 14382199     Source Type: Journal    
DOI: 10.1007/s00726-011-1148-z     Document Type: Article

References (78)

1. Aceto A, Dragani B, Melino S, Principato G, Saccucci F, Gualtieri G, Petruzzelli R (1998) Structural characterization of human glyoxalase II as probed by limited proteolysis. Biochem Mol Biol Int 44:761-769
2. Bekeredjian R, Chen S, Frenkel PA, Grayburn PA, Shohet RV (2003) Ultrasound-targeted microbubble destruction can repeatedly direct highly specific plasmid expression to the heart. Circulation 108:1022-1026
3. Bellamy W, Wakabayashi H, Takase M, Kawase K, Shimamura S, TomitaM (1993) Killing of Candida albicans by lactoferricin B, a potent antimicrobial peptide derived fromthe N-terminal region of bovine lactoferrin. Med Microbiol Immunol 182:97-105
4. Bennett RM, Bagby GC, Davis J (1981) Calcium-dependent polymerization of lactoferrin. Biochem Biophys Res Commun 101:88-95
5. Bezault J, Bhimani R, Wiprovnick J, Furmanski P (1994) Human lactoferrin inhibits growth of solid tumors and development of experimental metastases in mice. Cancer Res 54:2310-2312
6. Bhimani RS, Vendrov Y, Furmanski P (1999) Influence of lactoferrin feeding and injection against systemic staphylococcal infections in mice. J Appl Microbiol 86:135-144
7. Bielinska AU, Kukowska-Latallo JF, Baker JR Jr (1997) The interaction of plasmid DNA with polyamidoamine dendrimers: mechanism of complex formation and analysis of alterations induced in nuclease sensitivity and transcriptional activity of the complexed DNA. Biochim Biophys Acta 1353:180-190
8. Boussif O, Lezoualc'h F, Zanta MA, Mergny MD, Scherman D, Demeneix B, Behr JP (1995) A versatile vector for gene and oligonucleotide transfer into cells in culture and in vivo: polyethylenimine. Proc Natl Acad Sci USA 92:7297-7301
9. Browning RJ, Mulvana H, Tang M, Hajnal JV, Wells DJ, Eckersley RJ (2011) Influence of needle gauge on in vivo ultrasound and microbubble-mediated gene transfection. Ultrasound Med Biol 37:1531-1537
10. Caliceti P, Veronese FM (2003) Pharmacokinetic and biodistribution properties of poly(ethylene glycol)-protein conjugates. Adv Drug Deliv Rev 55:1261-1277
11. Cavalieri F, Ashokkumar M, Grieser F, Caruso F (2008) Ultrasonic synthesis of stable, functional lysozyme microbubbles. Langmuir 24:10078-10083
12. Cavalieri F, Zhou M, Ashokkumar M (2010) The design of multifunctional microbubbles for ultrasound image-guided cancer therapy. Curr Top Med Chem 10:1198-1210
13. Dang SP, Wang RX, Qin MD, Zhang Y, Gu YZ, Wang MY, Yang QL, Li XR, Zhang XG (2011) A novel transfection method for eukaryotic cells using polyethylenimine coated albumin microbubbles. Plasmid 66:19-25
14. de Jong N, Frinking PJ, Bouakaz A, Goorden M, Schourmans T, Jingping X, Mastik F (2000) Optical imaging of contrast agent microbubbles in an ultrasound field with a 100-MHz camera. Ultrasound Med Biol 26:487-492
15. Deelman LE, Decleves AE, Rychak JJ, Sharma K (2010) Targeted renal therapies through microbubbles and ultrasound. Adv Drug Deliv Rev 62:1369-1377
16. Deng CX, Sieling F, Pan H, Cui J (2004) Ultrasound-induced cell membrane porosity. Ultrasound Med Biol 30:519-526
17. Dial EJ, Romero JJ, Headon DR, Lichtenberger LM (2000) Recombinant human lactoferrin is effective in the treatment of Helicobacter felis-infected mice. J Pharm Pharmacol 52:1541-1546
18. Dobson CM (2003) Protein folding and disease: a view from the first horizon symposium. Nat Rev Drug Discov 2:154-160
19. During K, Porsch P, Mahn A, Brinkmann O, Gieffers W (1999) The non-enzymatic microbicidal activity of lysozymes. FEBS Lett 449:93-100
20. Elrod KC, Moore WR, Abraham WM, Tanaka RD (1997) Lactoferrin, a potent tryptase inhibitor, abolishes late-phase airway responses in allergic sheep. Am J Respir Crit Care Med 156:375-381
21. Ferrara KW (2008) Driving delivery vehicles with ultrasound. Adv Drug Deliv Rev 60:1097-1102
22. Fink AL (1998) Protein aggregation: folding aggregates, inclusion bodies and amyloid. Fold Des 3:R9-R23
23. Fontana A, Fassina G, Vita C, Dalzoppo D, Zamai M, Zambonin M (1986) Correlation between sites of limited proteolysis and segmental mobility in thermolysin. Biochemistry 25:1847-1851
24. Fontana A, Polverino de Laureto P, de Filippis V, Scaramella E, Zambonin M (1997) Probing the partly folded states of proteins by limited proteolysis. Fold Des 2:R17-R26
25. Grinstaff MW, Suslick KS (1991) Air-filled proteinaceous microbubbles: synthesis of an echo-contrast agent. Proc Natl Acad Sci USA 88:7708-7710
26. Hashiya N, Aoki M, Tachibana K, Taniyama Y, Yamasaki K, Hiraoka K, Makino H, Yasufumi K, Ogihara T, Morishita R (2004) Local delivery of E2F decoy oligodeoxynucleotides using ultrasound with microbubble agent (Optison) inhibits intimal hyperplasia after balloon injury in rat carotid artery model. Biochem Biophys Res Commun 317:508-514
27. Hauff P, Seemann S, Reszka R, Schultze-Mosgau M, Reinhardt M, Buzasi T, Plath T, Rosewicz S, Schirner M (2005) Evaluation of gas-filled microparticles and sonoporation as gene delivery system: feasibility study in rodent tumor models. Radiology 236:572-578
28. Hernot S, Klibanov AL (2008) Microbubbles in ultrasound-triggered drug and gene delivery. Adv Drug Deliv Rev 60:1153-1166
29. Ikeda M, Nozaki A, Sugiyama K, Tanaka T, Naganuma A, Tanaka K, Sekihara H, Shimotohno K, Saito M, Kato N (2000) Characterization of antiviral activity of lactoferrin against hepatitis C virus infection in human cultured cells. Virus Res 66:51-63
30. Inoue M, Okamura T, Yasui M, Sakata N, Yagi K, Kawa K (2001) Lactoferrin for gut GVHD. Bone Marrow Transplant 28:1091-1092
31. Kanyshkova TG, Buneva VN, Nevinsky GA (2001) Lactoferrin and its biological functions. Biochemistry (Mosc) 66:1-7
32. Kaufmann BA, Lindner JR (2007) Molecular imaging with targeted contrast ultrasound. Curr Opin Biotechnol 18:11-16
33. Krebs MR, Wilkins DK, Chung EW, Pitkeathly MC, Chamberlain AK, Zurdo J, Robinson CV, Dobson CM (2000) Formation and seeding of amyloid fibrils from wild-type hen lysozyme and a peptide fragment from the beta-domain. J Mol Biol 300:541-549
34. Kuhara T, Iigo M, Itoh T, Ushida Y, Sekine K, Terada N, Okamura H, Tsuda H (2000) Orally administered lactoferrin exerts an antimetastatic effect and enhances production of IL-18 in the intestinal epithelium. Nutr Cancer 38:192-199
35. Laemmli UK (1970) Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 227:680-685
36. Lentacker I, De Geest BG, Vandenbroucke RE, Peeters L, Demeester J, De Smedt SC, Sanders NN (2006) Ultrasound-responsive polymer-coated microbubbles that bind and protect DNA. Langmuir 22:7273-7278
37. Li YS, Davidson E, Reid CN, McHale AP (2009) Optimising ultrasound-mediated gene transfer (sonoporation) in vitro and prolonged expression of a transgene in vivo: potential applications for gene therapy of cancer. Cancer Lett 273:62-69
38. Liu Y, Miyoshi H, Nakamura M (2006) Encapsulated ultrasound microbubbles: therapeutic application in drug/gene delivery. J Control Release 114:89-99
39. Mantel C, Miyazawa K, Broxmeyer HE (1994) Physical characteristics and polymerization during iron saturation of lactoferrin, a myelopoietic regulatory molecule with suppressor activity. Adv Exp Med Biol 357:121-132
40. Martwiset S, Koh AE, Chen W (2006) Nonfouling characteristics of dextran-containing surfaces. Langmuir 22:8192-8196
41. Mayer S, Grayburn PA (2001) Myocardial contrast agents: recent advances and future directions. Prog Cardiovasc Dis 44:33-44
42. Mehier-Humbert S, Guy RH (2005) Physical methods for gene transfer: improving the kinetics of gene delivery into cells. Adv Drug Deliv Rev 57:733-753
43. Meijering BD, Juffermans LJ, van Wamel A, Henning RH, Zuhorn IS, Emmer M, Versteilen AM, Paulus WJ, van Gilst WH, Kooiman K, de Jong N, Musters RJ, Deelman LE, Kamp O (2009) Ultrasound and microbubble-targeted delivery of macromolecules is regulated by induction of endocytosis and pore formation. Circ Res 104:679-687
44. Mela I, Aumaitre E, Williamson AM, Yakubov GE (2010) Charge reversal by salt-induced aggregation in aqueous lactoferrin solutions. Colloids Surf B Biointerfaces 78:53-60
45. Melino S, Cicero DO, Forlani F, Pagani S, Paci M (2004) The N-terminal rhodanese domain from Azotobacter vinelandii has a stable and folded structure independently of the C-terminal domain. FEBS Lett 577:403-408
46. Midoux P, Breuzard G, Gomez JP, Pichon C (2008) Polymer-based gene delivery: a current review on the uptake and intracellular trafficking of polyplexes. Curr Gene Ther 8:335-352
47. Mine Y, Ma F, Lauriau S (2004) Antimicrobial peptides released by enzymatic hydrolysis of hen egg white lysozyme. J Agric Food Chem 52:1088-1094
48. Mitra S, Gaur U, Ghosh PC, Maitra AN (2001) Tumour targeted delivery of encapsulated dextran-doxorubicin conjugate using chitosan nanoparticles as carrier. J Control Release 74:317-323
49. Moseley ME, Wendland MF, Rampil I, Barnhart J (1991) Microbubbles: a novel MR susceptibility con-trast agent In: Proceedings of the 10th annual meeting of the ISMRM. San Francisco, California USA, p 1020
50. Muller FM, Lyman CA, Walsh TJ (1999) Antimicrobial peptides as potential new antifungals. Mycoses 42(Suppl 2):77-82
51. Nair A, Thevenot P, Dey J, Shen J, Sun MW, Yang J, Tang L (2010) Novel polymeric scaffolds using protein microbubbles as porogen and growth factor carriers. Tissue Eng Part C Methods 16:23-32
52. Ng KY, Liu Y (2002) Therapeutic ultrasound: its application in drug delivery. Med Res Rev 22:204-223
53. Nishikawa M, Huang L (2001) Nonviral vectors in the new millennium: delivery barriers in gene transfer. Hum Gene Ther 12:861-870
54. Porter TR, Xie F, Kilzer K (1995a) Intravenous perfluoropropaneexposed sonicated dextrose albumin produces myocardial ultrasound contrast that correlates with coronary blood flow. J Am Soc Echocardiogr 8:710-718
55. Porter TR, Xie F, Kilzer K (1995b) Intravenous perfluoropropaneexposed sonicated dextrose albumin produces myocardial ultrasound contrast that correlates with coronary blood flow. J Am Soc Echocardiogr 8:710-718
56. Porter TR, Hiser WL, Kricsfeld D, Deligonul U, Xie F, Iversen P, Radio S (2001) Inhibition of carotid artery neointimal formation with intravenous microbubbles. Ultrasound Med Biol 27:259-265
57. Sacchettini JC, Kelly JW (2002) Therapeutic strategies for human amyloid diseases. Nat Rev Drug Discov 1:267-275
58. Selkoe DJ (2003) Folding proteins in fatal ways. Nature 426:900-904
59. Semba RD, Miotti PG, Lan Y, Chiphangwi JD, Hoover DR, Dallabetta GA, Yang LP, Saah AJ (1998) Maternal serum lactoferrin and vertical transmission of HIV. Aids 12:331-332
60. Shimamura M, Sato N, Taniyama Y, Yamamoto S, Endoh M, Kurinami H, Aoki M, Ogihara T, Kaneda Y, Morishita R (2004) Development of efficient plasmid DNA transfer into adult rat central nervous system using microbubble-enhanced ultrasound. Gene Ther 11:1532-1539
61. Stefani M, Dobson CM (2003) Protein aggregation and aggregate toxicity: new insights into protein folding, misfolding diseases and biological evolution. J Mol Med 81:678-699
62. Sunde M, Blake C (1997) The structure of amyloid fibrils by electron microscopy and X-ray diffraction. Adv Protein Chem 50:123-159
63. Superti F, Ammendolia MG, Valenti P, Seganti L (1997) Antirotaviral activity of milk proteins: lactoferrin prevents rotavirus infection in the enterocyte-like cell line HT-29. Med Microbiol Immunol 186:83-91
64. Swart PJ, Kuipers EM, Smit C, Van Der Strate BW, Harmsen MC, Meijer DK (1998) Lactoferrin. Antiviral activity of lactoferrin. Adv Exp Med Biol 443:205-213
65. Tanaka T, Omata Y, Isamida T, Saito A, Shimazaki K, Yamauchi K, Suzuki N (1998) Growth inhibitory effect of bovine lactoferrin to Toxoplasma gondii tachyzoites in murine macrophages: tyrosine phosphorylation in murine macrophages induced by bovine lactoferrin. J Vet Med Sci 60:369-371
66. Taniyama Y, Tachibana K, Hiraoka K, Aoki M, Yamamoto S, Matsumoto K, Nakamura T, Ogihara T, Kaneda Y, Morishita R (2002) Development of safe and efficient novel nonviral gene transfer using ultrasound: enhancement of transfection efficiency of naked plasmid DNA in skeletal muscle. Gene Ther 9:372-380
67. Tsunoda S, Mazda O, Oda Y, Iida Y, Akabame S, Kishida T, Shin-Ya M, Asada H, Gojo S, Imanishi J, Matsubara H, Yoshikawa T (2005) Sonoporation using microbubble BR14 promotes pDNA/siRNA transduction to murine heart. Biochem Biophys Res Commun 336:118-127
68. Unger EC, Hersh E, Vannan M, Matsunaga TO, McCreery T (2001a) Local drug and gene delivery through microbubbles. Prog Cardiovasc Dis 44:45-54
69. Unger EC, Hersh E, Vannan M, McCreery T (2001b) Gene delivery using ultrasound contrast agents. Echocardiography 18:355-361
70. Unger EC, Matsunaga TO, McCreery T, Schumann P, Sweitzer R, Quigley R (2002) Therapeutic applications of microbubbles. Eur J Radiol 42:160-168
71. Unger EC, Porter T, Culp W, Labell R, Matsunaga T, Zutshi R (2004) Therapeutic applications of lipid-coated microbubbles. Adv Drug Deliv Rev 56:1291-1314
72. Villanueva FS, Jankowski RJ, Manaugh C, Wagner WR (1997) Albumin microbubble adherence to human coronary endothelium: implications for assessment of endothelial function using myocardial contrast echocardiography. J Am Coll Cardiol 30:689-693
73. Wakabayashi H, Takakura N, Yamauchi K, Teraguchi S, Uchida K, Yamaguchi H, Tamura Y (2002) Effect of lactoferrin feeding on the host antifungal response in guinea-pigs infected or immunised with Trichophyton mentagrophytes. J Med Microbiol 51:844-850
74. Wong KK, Huang I, Kim YR, Tang H, Yang ES, Kwong KK, Wu EX (2004) In vivo study of microbubbles as an MR susceptibility contrast agent. Magn Reson Med 52:445-452
75. Wu J, Pepe J, Rincon M (2006) Sonoporation, anti-cancer drug and antibody delivery using ultrasound. Ultrasonics 44(Suppl 1):21-25
76. Yuan QY, Huang J, Chu BC, Li XS, Si LY (2011) A visible, targeted high-efficiency gene delivery and transfection strategy. BMC Biotechnol 11:56
77. Zhou M, Cavalieri F, Ashokkumar M (2011) Instrumentation science and technology (in press)
78. Zhou M, Cavalieri F, Ashokkumar M (2011b) Tailoring the properties of ultrasonically synthesised microbubbles. Soft Matter 7:623-630